Quantitative MRI provides important information about tissue properties in 30 brain both in normal ageing and in degenerative disorders. Although it is well 31 known that those with Alzheimer's disease (AD) show a specific pattern and 32 faster rate of atrophy than controls, the precise spatial and temporal patterns 33 of quantitative MRI in AD are unknown. We aimed to investigate 34 neuroimaging correlates of AD using serial quantitative MRI. In our study, 35 twenty-one subjects with AD and thirty-two similar-aged healthy controls 36 underwent two serial MRI scans at baseline and 12 months. Tissue 37 characteristics were captured using two quantitative MRI parameters: 38 longitudinal relaxation time (qT1) and transverse relaxation time (qT2). The 39 two groups (AD and controls) were statistically compared using a voxel based 40 quantification (VBQ) method based on Matlab and SPM8. At baseline, 41 subjects with AD showed a significant reduction of qT1 and qT2 compared to 42 controls in bilateral temporal and parietal lobes, hippocampus, and basal 43 ganglia. This pattern was also observed at follow-up. Longitudinally, in AD we 44 found a significant increase rather than further reduction of qT1 and qT2 from 45 the baseline in bilateral hippocampus, thalamus and right caudate nucleus. In 46 addition, the longitudinal change of qT1 in left hippocampus was negatively 47 correlated with cognitive decline in AD over the 1-year period, and the general 48 
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Quantitative mapping of tissue qT1 and qT2 relaxation times was performed 137 using custom designed MRI sequences developed in-house under a research 138 agreement with Philips Medical Systems. 139 140 Fast qT1 mapping was based on the inversion recovery (IR) methods 141 originally published by Ordidge et al [14] and expanded by Clare and Jezzard 142 [15] . The sequence imaged 72 axial slices spanning the brain, which were 143 grouped into 5 consecutive slabs each of thickness 24mm. For each slab a 144 slice selective adiabatic (sech) inversion pulse was applied to invert the 145 magnetisation ensuring that the region of full inversion encompassed the 24 146 mm thick section of interest. This inversion was followed by slice selective 147 single shot EPI readout of 12 contiguous slices of 2 mm thickness equally 148 spaced across the slab. The first slice was imaged 250ms post inversion and 149 subsequent slices every 205 ms thereafter. During the repetition time (TR) of 150 15000ms each slab was inverted and imaged with a slab order of 1,3,5,2,4 to 151 minimise interaction between slices. In this way the time between inverting 152 adjacent slabs was 6000ms, sufficient to allow full relaxation of brain tissue. 153
The sequence was repeated 12 times and on each repetition the order of 154 acquired slices within each slab was permuted by one position, for example 
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where T IR is the inversion time, S(T IR ) is the signal value or the data obtained 173 from the inversion recovery experiment, qT1 is the longitudinal relaxation 174 time, S o is the proton density and  is the effective inversion efficiency . qT1,
175
S o and were computed pixel-wise from the fitting process. Ideally is 176 expected to be 2 but it was allowed to be a free variable in the fitting in order 177 to increase the accuracy of the computed qT1. The 3D images of proton 178 density S 0 , qT1, and the goodness of fit were saved for evaluation. the previously validated voxel-based quantification (VBQ) procedure [4] . At 214 both baseline and follow-up, raw qT1 and qT2 imaging datasets were 215 corrected for field inhomogeneities using B0 maps and the PRELUDE/FUGUE 216 algorithm in FSL [16] . Then, the bias corrected qT1 and qT2 maps were used 217 for subsequent analysis. 218
219
Volumetric structural T1 weighted images were firstly segmented using 220
Gaussian mixture model implemented in the VBM toolbox [17] , and brain 221 tissues were classified into grey matter (GM), white matter (WM) and 222
Cerebrospinal fluid (CSF) for both baseline and follow-up. A conjunction GM 223 brain mask was generated for each individual subject (in both AD and control 224 groups) by computing the intersection between the GM probability maps at 225 the baseline and that at the follow-up of the same subject, and then 226 thresholded at p>0.5 in each participant's native space. This mask was used 227 to select a common area of GM tissue at both baseline and follow-up in order 228
to ensure there were equal number of voxels tested in both time points, thus 229 avoiding potential bias in the statistical analysis. 230
231
As in standard longitudinal VBM procedure, only the baseline GM probability 232 maps were non-linearly normalized to standard MNI space 233 (www.mni.mcgill.ca) using the diffeomorphic registration algorithm (DARTEL) 234 [17] in SPM, and the resulting parameters were used to normalize the qT1 235 and qT2 maps in both baseline and follow-up. The qT1 and qT2 maps at both 236 time points were firstly co-registered with the GM probability maps derived 237 from structural T1 images at baseline, then the thresholded conjunction GM 238 brain masks were applied to qT1 and qT2 data at both time points. Finally, we 239 transformed the GM maps of qT1 and qT2 MRI parameters into standard MNI 240 space using the participant-specific diffeomorphic parameters estimated from 241 the baseline scans based on the previous DARTEL procedure. However, we 242 did not apply modulation to these quantitative MRI parameters in order to 243 avoid confound of age and disease related GM volume changes. Finally, all 244 normalized quantitative qT1 and qT2 maps were smoothed with an isotropic 245 Gaussian kernel of 6 mm full width at half maximum. 246
247
For statistical analysis investigating disease induced regional microstructural 248 alterations between the AD and control groups, and between the baseline and 249 follow-up, we used the General Linear Model (GLM) with age and gender as 250 covariates. Then, two-tailed t-tests were performed at each voxel to detect 251 voxel-wise difference between the groups or time points. We also tested the 252 group x time interaction using a mixed model ANOVA. The false positive rate 253 was controlled using family-wise error (FWE) correction for multiple 254 comparisons, and thresholded at p<0.05 at the cluster level. 
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Results
269
Demographic clinical and cognitive measures 270
As shown in Table 1 , there were no significant differences between AD and 271 control groups for age, sex and educational level. However, as expected, the 272 two groups significantly different at both baseline and follow-up for UPDRS III, 273 NPI, MMSE and CAMCOG scores with subjects with AD scoring poorer in all 274 measures compared to the controls. 275
276
Insert Table 1 here 277
278
Cross-sectional comparison of qT1: AD vs. controls 279
13
As shown in Figure 2A and Table 2A , at the baseline, we found a significant 280 decrease in qT1 for the AD group compared to controls (p<0.0001, FWE) in 281 bilateral temporal, parietal and occipital lobes, as well as several subcortical / 282 striatal nuclei. Largest significant clusters were within bilateral hippocampus, 283 parahippocampus, cuneus, precuneus, caudate and putamen. At the follow-284 up, we found a very similar pattern of qT1 changes comparing between AD 285 and control groups. See Figure 2B and Table 2B . Table 2 here 290 291 Insert Figure 2 here 292 293
Cross-sectional comparison of qT2: AD vs. controls 294
For qT2 at the baseline, we also found a significant decrease for the AD group 295 compared to controls (p<0.0001, FWE) in left superior and right middle 296 temporal lobes, bilateral hippocampus and left parahippocampus as shown in 297 Figure 3A and Table 3A . At the follow-up, we found a very similar pattern of 298 qT2 changes comparing between AD and control groups except for a cluster 299 covering left caudate, putamen and pallidum, and a right cuneus cluster, 300 which were not seen at the baseline. See Figure 3B and Table 3B . No 301 significant increase in qT2 was found for the AD group compared to controls 302 at either baseline or follow-up. 303
304
Insert Table 3 here 305
306
Insert Figure 3 here 307 308
Longitudinal comparison of qT1: baseline vs. follow-up 309
When comparing qT1 between baseline and follow-up in the AD group, we 310 found a significant increase over 12 months in bilateral hippocampus and 311 parahippocampus (p<0.0001, FWE), thalamus (p<0.0001 for left and p=0.002 312 for right, FWE) and right caudate (p<0.0001, FWE) as shown in Figure 2C  313 and Table 4A . The significant hippocampus clusters in the longitudinal 314 comparison are more medial to the clusters found in the cross-sectional 315 comparisons; see Figure 2 . We found no longitudinal change for qT1 in the 316 control group and no group (AD and controls) x time (baseline and follow-up) 317
interaction. 318 319
Insert Table 4 here 320 321
Longitudinal comparison of qT2: baseline vs. follow-up 322
For qT2, we found a significant increase between the baseline and the follow-323 up in the AD group as shown in Figure 3C and Table 4B . Significant clusters 324 are located in left parahippocampus (p<0.0001, FWE), right caudate, putamen 325 and insula (p<0.0001, FWE), as well as right middle frontal lobe (p=0.002, 326 FWE). We found a significant group x time interaction in right insula 327 (p<0.0001, FWE) bordering with right putamen and extending to right caudate 328 at lower threshold (p<0.001, uncorrected). We argue that atrophy is unlike the 329 explanation of this effect because if atrophy were a driver of an increase in 330 qT2 over time, we would expect AD subjects at baseline to have a greater 331 qT2 than controls because of their greater atrophy, a result opposite to what 332 we found here. 333
334
For the control group, we found a significant longitudinal increase in qT2 335 MRI within the AD group, and how it relates to disease severity. It can be 377 seen in Figure 4A that subjects with AD showed a general increase in qT1 in 378 right hippocampus, and the rate of increase seems to accelerate in moderate 379 and severe cases of AD, i.e. baseline MMSE score lower than 20. The same 380 pattern was observed in other clusters found in the longitudinal analysis. 381 Using novel longitudinal and quantitative MRI method and voxel-based 391 quantification, we showed that at the cross-sectional level, qT1 and qT2 in AD 392
were significantly decreased in multiple cortical areas in bilateral temporal and 393 parietal lobes with the largest changes in medial temporal structures 394 comparing to similarly aged control subjects at baseline. This pattern is 395 consistent with previous neuroimaging studies with AD showing significant 396 volume reduction in these regions such as hippocampal, enthorinal and 397 parahippocampal cortices [18] . It is worth noting that both qT1 and qT2 parameters consistently picked up 407 substantial changes in subcortical regions, e.g. bilateral caudate, putamen 408 and thalamus. However, comparing to neocortex, in particular the 409 hippocampus, these basal nuclei and thalamus have received much less 410 attention in previous research, and conventional volumetric MRI showed a 411 mixed picture of atrophy in these subcortical areas. For example, atrophy of 412 putamen was found in DLB but not in AD [19] , whereas putamen and thalamic 413 atrophy were both shown in AD in a different study [20] reflecting a relatively 414 high level of noise in volumetric measures in these regions and large inter-415 study variability. In contrast, quantitative MRI may detect neuronal and 416 macromolecular changes in tissue environment, which does not rely on 417 atrophy shown in structural T1 weighted MRI. Based on this, we argue that 418 qMRI provides incremental benefit over and above that of structural MRI. 419
Quantitative MRI also offers a unique opportunity to detect early brain 420 changes in AD before observable brain volume reduction can be reliably 421 shown and cognitive / clinical impairments can be found [2] . 422
423
Although we found that AD was characterized by a reduction in qMRI 424 AD [31, 32] probably reflecting a complex interaction between β-amyloid and 499 iron concentration as well as other factors. 500
501
In a longitudinal study of β-amyloid plaque development in Tg2576 transgenic 502 mice using qT2 relaxation time [33] , it has been found that qT2 decreases 503 with age (12 -18 months) following an increase in plaque area, number and 504 size in the brain. Although it is difficult to match the disease stage of the 505 mouse model to humans with AD and it is not common to find atrophy in the 506 animal model of AD, this finding is nonetheless consistent with our results 507
showing decreased qT2 in medial temporal lobes in AD. It has also been 508 shown in a study based on APP/PS1 transgenic mice model that qT2 is 509 modulated by the level of amyloid in subiculum without histochemically 510 detectable iron in the brain [34] , providing promises in detecting the 511 pathological process in AD at the earliest stages. 512
513
In addition to our previous findings on qMRI changes in DLB [7] , as well as 514 the established literature on animal qMRI correlates, the current data provided 515 convergent evidence for the potential ability of quantitative MRI in detecting 516 early changes of tissue property caused by neurodegenerative disease. Being 517 able to apply this novel technique in human using relatively safe MRI method 518 enables new means for early detection of AD and tracking its progression 519 over time. This approach is also likely to close the gap between animal 520 models of amyloidosis and studies on human AD in the context of drug 521 discovery. 
